Universal Drugstore logo

What Is Lynkuet?

Key Takeaways

  • Lynkuet is a non-hormonal medication used to treat menopausal symptoms, especially moderate to severe hot flashes and night sweats.
  • The drug contains elinzanetant, a neurokinin receptor antagonist that targets neurokinin 1 and neurokinin 3 receptors involved in vasomotor symptoms.
  • Lynkuet is designed to help reduce vasomotor symptoms without using estrogen or traditional hormone therapy.
  • Like many prescription medications, Lynkuet may cause side effects, most commonly headache, drowsiness, and dizziness.

Overview of Lynkuet

Lynkuet is a medication from Bayer that is FDA-approved for the treatment of vasomotor symptoms, which include hot flashes and night sweats commonly associated with menopause.

The active ingredient in Lynkuet is elinzanetant, a compound that works differently from traditional hormone therapy. Instead of replacing estrogen, the drug targets specific receptors in the brain that regulate body temperature.

Menopausal hot flashes and night sweats can significantly affect quality of life, sleep, and daily functioning. Lynkuet aims to provide a non-hormonal treatment option for people who cannot or prefer not to use hormone replacement therapy.

What Conditions Lynkuet Is Intended to Treat

Lynkuet is approved for the treatment of moderate to severe vasomotor symptoms in menopausal women.

Vasomotor symptoms (VMS) are among the most common menopausal symptoms and can include:

  • Severe hot flashes
  • Night sweats
  • Sleep disturbances related to temperature changes
  • Sudden flushing or sweating episodes

These symptoms occur when hormonal changes during menopause affect the brain’s temperature regulation system. Taking Lynkuet can improve the quality of life for people experiencing these symptoms.

How Lynkuet Works

Lynkuet works by targeting neurokinin receptors in the brain that are involved in regulating body temperature.

The medication contains elinzanetant, which acts as a receptor antagonist for both neurokinin 1 and neurokinin 3 receptors. These receptors interact with signaling molecules such as kisspeptin, neurokinin B, and dynorphin that are part of the KNDy neuron system in the hypothalamus.

KNDy neurons play a key role in controlling temperature regulation and hormone signaling during menopause. When estrogen levels decline, activity in these neurons may increase, triggering vasomotor symptoms.

By blocking neurokinin receptors, elinzanetant may help stabilize temperature regulation and reduce hot flashes and night sweats.

Clinical Trials Studying Lynkuet

The safety and effectiveness of Lynkuet have been evaluated in several clinical trials, including OASIS 1, OASIS 2, and OASIS 3.

When compared to placebo, elinzanetant improved the frequency and severity of hot flashes, sleep disturbances, and overall quality of life.

Possible Side Effects of Lynkuet

Like many medications, Lynkuet may cause side effects in some people.

The most common side effects reported in clinical trials include:

  • Headache
  • Fatigue
  • Stomach pain
  • Muscle spasms

Because the medication acts on central nervous system receptors, some individuals may experience other symptoms depending on how the body responds to treatment.

Serious Side Effects and Safety Concerns

Although uncommon, some serious side effects may occur.

Potential concerns include:

  • Liver problems detected through blood tests
  • Allergic reactions
  • Possible interactions with medications that affect liver enzymes

Individuals with a history of seizures or certain medical conditions may need careful evaluation before using medications that act on neurological pathways.

A healthcare provider may recommend monitoring liver function through blood tests during treatment.

Who May Consider Lynkuet

Lynkuet may be an option for menopausal women who experience moderate to severe vasomotor symptoms but cannot use hormone therapy.

Some people avoid hormone replacement therapy due to personal preference or medical history, including:

  • Breast cancer or hormone-sensitive cancers
  • Increased risk related to estrogen therapy
  • Concerns about long-term hormone use

For these individuals, non-hormonal treatments may offer an alternative approach to managing menopausal symptoms.

Drug Interactions and Safety Considerations

Certain medications or supplements may interact with some Inhibitors (grapefruit juice) or inducers of liver enzymes.

Anyone considering Lynkuet should review all medications, supplements, and health conditions with a healthcare professional.

When to Talk to a Healthcare Provider

A healthcare provider may help determine whether treatment is appropriate by considering factors such as:

  • Severity and frequency of vasomotor symptoms
  • Medical history and risk factors
  • Prior experience with hormone therapy
  • Impact of symptoms on sleep and daily life

Women experiencing persistent menopausal symptoms should discuss available treatment options with a healthcare professional.

The Bottom Line

Lynkuet is a non-hormonal medication under development for the treatment of moderate to severe vasomotor symptoms associated with menopause. The drug contains elinzanetant, which targets neurokinin receptors involved in the brain’s temperature regulation system.

By acting on these pathways, Lynkuet may help reduce hot flashes, night sweats, and related sleep disturbances. As research continues and regulatory review progresses, medications like Lynkuet may expand treatment options for menopausal women seeking alternatives to hormone therapy.

Frequently Asked Questions

What is Lynkuet used for?

Lynkuet is being developed to treat moderate to severe vasomotor symptoms associated with menopause. These symptoms include hot flashes and night sweats that can disrupt sleep and daily activities.

Is Lynkuet a hormone therapy?

No, Lynkuet is designed as a non-hormonal treatment option. Instead of using estrogen, the medication works by blocking neurokinin receptors involved in temperature regulation.

What is the active ingredient in Lynkuet?

The active ingredient in Lynkuet is elinzanetant. This compound is a neurokinin receptor antagonist that targets neurokinin 1 and neurokinin 3 pathways in the brain.

Can you take Lynkuet if you are pregnant?

Animal studies show that Lynkuet may harm your unborn baby or cause a pregnancy loss. If you can get pregnant, you should take a pregnancy test before starting Lynkuet. You should use an effective method of birth control while taking this medication and for 2 weeks after the last dose. If you become pregnant, tell your healthcare provider immediately.

What are some common side effects of Lynkuet?

Common side effects reported in clinical trials include headache, fatigue, dizziness, and muscle spasms. A healthcare provider can help determine whether this treatment is appropriate based on your medical history.

Sources